The FDA has recently cleared the American Medical System’s RetroArc Retropubic Sling System as a treatment of female stress urinary incontinence (SUI). Affecting roughly 13 million women in the US, SUI causes the involuntary loss of urine during coughing, laughing, or sneezing. The RetroArc is a minimally invasive that can be used to treat SUI through an outpatient procedure. It consists of two 4mm diameter needles that provide flexural rigidity as they’re advances through the vaginal cavity. The system also uses a polypropylene monofilament mesh sling that promotes fibrous tissue integration and improved healing. The video above is an animation of the implantation of RetroArc.
(Source: PR Newswire)